De Boeck et al. have shown that IL-33 derived from glioma cells and a subset of Iba1+ microglia increases phosphorylated STAT3 (p-STAT3), potentially upregulating the expression of downstream LIF and IL-6 in both cell types [59,60]. The gene discussed is STAT3; the disease is central nervous system cancer.